Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
Saved in:
Main Authors: | Daniel A. Ladin (Author), Eman Soliman (Author), LaToya Griffin (Author), Rukiyah Van Dross (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
by: Daniel A. Ladin, et al.
Published: (2016) -
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
by: Ken Soderstrom, et al.
Published: (2017) -
Apoptosis mechanisms induced by 15d-PMJ2 in HCT116 colon cancer cells: insights into CHOP10/TRB3/Akt signaling
by: Hussam Albassam, et al.
Published: (2023) -
Kinin B1R Activation Induces Endoplasmic Reticulum Stress in Primary Hypothalamic Neurons
by: Acacia White, et al.
Published: (2022) -
PENINGKATAN KARAKTER TANGGUNG JAWAB MELALUI METODE PROYEK PADA ANAK KELOMPOK B TK MARFU'AH PALEMBANG
by: Mega Seftyana, et al.
Published: (2019)